5FXS

IGFR-1R complex with a pyrimidine inhibitor.

5FXS の概要

• エントリーDOI: 10.2210/pdb5fxs/pdb
• 関連するPDBエントリー: 5FXQ 5FXR
• 分子名称: INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR, ACETATE ION, 2-[4-[4-[[(6Z)-5-chloranyl-6-pyrazolo[1,5-a]pyridin-3-ylidene-1H-pyrimidin-2-yl]amino]-3,5-dimethyl-pyrazol-1-yl]piperidin-1-yl]-N,N-dimethyl-ethanamide, ... (4 entities in total)
• 機能のキーワード: transferase
• 由来する生物種: HOMO SAPIENS (HUMAN)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 35850.45

構造登録者

Degorce, S.,Boyd, S.,Curwen, J.,Ducray, R.,Halsall, C.,Jones, C.,Lach, F.,Lenz, E.,Pass, M.,Pass, S.,Trigwell, C.,Norman, R.,Phillips, C. (登録日: 2016-03-02, 公開日: 2016-10-19, 最終更新日: 2025-12-24)

主引用文献

Degorce, S.L.,Boyd, S.,Curwen, J.O.,Ducray, R.,Halsall, C.T.,Jones, C.D.,Lach, F.,Lenz, E.M.,Pass, M.,Pass, S.,Trigwell, C.
Discovery of a Potent, Selective, Orally Bioavailable, and Efficacious Novel 2-(Pyrazol-4-ylamino)-pyrimidine Inhibitor of the Insulin-like Growth Factor-1 Receptor (IGF-1R).
J. Med. Chem., 59:4859-4866, 2016

PubMed Abstract: Optimization of cellular lipophilic ligand efficiency (LLE) in a series of 2-anilino-pyrimidine IGF-1R kinase inhibitors led to the identification of novel 2-(pyrazol-4-ylamino)-pyrimidines with improved physicochemical properties. Replacement of the imidazo[1,2-a]pyridine group of the previously reported inhibitor 3 with the related pyrazolo[1,5-a]pyridine improved IGF-1R cellular potency. Substitution of the amino-pyrazole group was key to obtaining excellent kinase selectivity and pharmacokinetic parameters suitable for oral dosing, which led to the discovery of (2R)-1-[4-(4-{[5-chloro-4-(pyrazolo[1,5-a]pyridin-3-yl)-2-pyrimidinyl]amino}-3,5-dimethyl-1H-pyrazol-1-yl)-1-piperidinyl]-2-hydroxy-1-propanone (AZD9362, 28), a novel, efficacious inhibitor of IGF-1R.

PubMed: 27078757
DOI: 10.1021/acs.jmedchem.6b00203

実験手法

X-RAY DIFFRACTION (1.9 Å)